ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
06 May 2022

Acarix presents at Naventus Health Care Summit 2022

Press release Malmö, Sweden, May 6, 2022   Acarix presents at Naventus Health Care Summit 2022 Helen Ljungdahl Ro...
Continue reading
author-avatar acarix
Annual, English, IR, Listing Regulation, News, Regulatory, Report
November 18, 2024
20 Apr 2022

Acarix publishes the annual report for 2021

Press release Malmö, Sweden, April 20, 2022   Acarix publishes the annual report for 2021 Today, Wednesday April ...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
11 Apr 2022

Notice of Annual General Meeting in Acarix AB

Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convene...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
01 Apr 2022

FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis

Press release (MAR)Malmö, Sweden, April 1, 2022   FDA requests supplementary information for Acarix br...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Order, Regulatory, Sales
November 18, 2024
11 Mar 2022

Acarix receives strategic order for the CADScor®System in US

Press release (MAR)Malmö, Sweden, March 11, 2022   Acarix receives strategic order for the CADScor®System in U...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
10 Mar 2022

Acarix presents at the Redeye Artificial Intelligence Seminar 2022

Press release Malmö, Sweden, March 10, 2022   Acarix presents at the Redeye Artificial Intelligence Seminar 2022 ...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend
November 18, 2024
17 Feb 2022

Correction of press release: Acarix AB (publ) publishes Year-End Report 2021

Press release Malmö, Sweden, February 17, 2022   Correction of press release: Acarix AB (publ) publishes Year-End ...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend
November 18, 2024
17 Feb 2022

Acarix AB (publ) publishes Year-End Report 2021

Press release Malmö, Sweden, February 17, 2022   Acarix AB (publ) publishes Year-End Report 2021 Groundwork laid ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
09 Feb 2022

Acarix submits breakthrough designation request with FDA for heart failure diagnosis

Press release Malmö, Sweden, February 9, 2022   Acarix submits breakthrough designation request with FDA for heart...
Continue reading
author-avatar acarix
Corporate Information, English, Financial calendar, IR, Listing Regulation, News, Regulatory
November 18, 2024
09 Feb 2022

Acarix AB (publ) brings forward publication of interim report for fourth quarter to February 17, 2022

Press release Malmö, Sweden, February 9, 2022   Acarix AB (publ) brings forward publication of interim report for ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
07 Feb 2022

Acarix invites to virtual Capital Market Day

Press releaseMalmö, Sweden, February 7, 2022 Acarix invites to virtual Capital Market Day Acarix is stepping up commercializa...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Regulatory, Staff change
November 18, 2024
10 Jan 2022

Acarix appoints US based Helen Ljungdahl Round as new CEO

Press release (MAR)Malmö, Sweden, January 10, 2022 Acarix appoints US based Helen Ljungdahl Round as new CEO The Board of Acarix...
Continue reading
  • «
  • ‹
  • 10
  • 11
  • 12
  • 13
  • 14
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.